Webinar | Women’s Nutrition: Nourishing Womanhood From Pregnancy To Menopause
11 September | 12 PM ET: Register Now

Nusantics

A precision molecular diagnostics start-up that develops PCR and NGS-based solutions for both human and animal applications
2020
51-100
51-100
Jakarta, Jakarta Raya, Indonesia

Investment Funding

Last Funding Stage

Early Stage Venture

Total Funding Amount

$2.2M

Last Funding Date

14-09-2022

Startup Stage

Non-equity Assistance

Lead Investors

East Ventures

Revenue

$1M to $10M

People

Founders

About

Nusantics is a precision molecular diagnostics startup from Indonesia; we develop PCR and Next Generation Sequencing-based solutions to improve healthcare outcomes in both human and animal applications. We offer 3 types of products; single pathogen molecular diagnostics, syndromic molecular diagnostics, and microbiome diagnostics (NGS)

Something missing or incorrect on this page? Help us enrich this information